Investor Relations Captor Therapeutics ®
Information on transaction in Company shares under Article 19 MAR
Current Report No. 48/2022
Date of preparation: 28 December 2022
Subject: Information on transaction in Company shares under Article 19 MAR
Legal basis: Article 19(3) MAR – information on transactions carried out by persons discharging managerial responsibilities
The Management Board of Captor Therapeutics S.A. based in Wrocław ("the Company") informs that it received from Thomas Shepherd, Member of the Management Board - President of the Management Board,, the notification regarding transactions on the Company's shares (conclusion of a share subscription agreement) under Article 19(1) of the MAR Regulation. The share subscription agreement was entered into as part of the incentive program.
The content of the notification is attached to this report.